Fempro 2.5mg

Fempro 2.5mg is a medication used to treat breast cancer in women. It is an oral non-steroidal aromatase inhibitor that works by reducing the production of estrogen in the body, which in turn helps to slow down the growth of hormone-sensitive breast cancer.

Composition:

• Fempro 2.5mg: Letrozole (2.5mg)

Mechanism of Action:

Letrozole, the active ingredient in Fempro, works by:

1. Inhibiting the activity of aromatase, an enzyme that converts androgens (male hormones) into estrogens (female hormones) in the body.
2. Reducing the production of estrogen in the body, which slows down the growth of hormone-sensitive breast cancer cells.

Uses:

Fempro 2.5mg is used to treat:

1. Early breast cancer in women who have undergone surgery and radiation therapy.
2. Advanced breast cancer in women who have not responded to previous treatment.
3. Adjuvant treatment for breast cancer in women who are at high risk of relapse.

Dosage:

The recommended dosage of Fempro 2.5mg is:

1. 2.5mg taken once daily, with or without food.

Side Effects:

Common side effects of Fempro may include:

1. Hot flashes
2. Night sweats
3. Fatigue
4. Nausea and vomiting
5. Headache
6. Dizziness
7. Increased risk of bone fractures

Recommendation:

Fempro is recommended for women who have been diagnosed with breast cancer and have not responded to previous treatment or are at high risk of relapse. It is essential to discuss the benefits and risks of this medication with your healthcare provider before starting treatment.

Important Note:

• Fempro should not be used in combination with other medications that may increase the risk of osteoporosis or bone fractures.
• Patients taking Fempro should be closely monitored for signs of bone fractures, especially during the first year of treatment.
• Pregnant or breastfeeding women should not use Fempro, as it may harm the fetus or infant.
• Regular follow-up appointments with your healthcare provider are necessary to monitor the effectiveness of Fempro and to detect any potential side effects or complications.

Special Precautions:

• Patients with a history of osteoporosis or bone fractures should be closely monitored for signs of worsening bone health while taking Fempro.
• Patients taking Fempro should avoid taking other medications that may increase the risk of osteoporosis or bone fractures.
• Patients with a history of liver disease should be closely monitored for signs of liver damage while taking Fempro.